Greater trochanteric pain syndrome: predicting who will respond to a local glucocorticoid injection
Matthias Jarlborg(University Hospital of Geneva), Stéphane Genevay(University of Geneva), Axel Finckh(University Hospital of Geneva), Antonio Faundez(University Hospital of Geneva), MJ Nissen(University Hospital of Geneva), D. Courvoisier(University Hospital of Geneva), Laure Brulhart(Hospital Neuchâtel)
Cited by 8
Related Papers
What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Prevention and treatment of low back pain: evidence, challenges, and promising directions
|The Lancet|2018|2.5k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k